PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
1.74 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 1.618 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0 | 0.372 | 0.362 | 0.359 | 0.358 | 0.369 | 0.082 | 0.16 | 0.144 | 0.179 | 0.167 | 0.407 | 0.41 | 0.071 | 0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 0 | -0.372 | -0.362 | 1.259 | -0.358 | -0.369 | -0.082 | -0.16 | -0.144 | -0.179 | -0.167 | -0.407 | -0.41 | -0.071 | -0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0.778 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 16.947 | 14.256 | 12.824 | 13.023 | 13.586 | 13.843 | 15.073 | 15.025 | 13.666 | 11.462 | 11.836 | 12.167 | 9.162 | 7.664 | 7.5 | 6.181 | 5.992 | 5.804 | 5.955 | 5.699 | 4.895 | 5.083 | 5.083 |
General & Administrative Expenses
| 4.941 | 5.542 | 5.035 | 5.52 | 6.042 | 6.279 | 6.407 | 6.137 | 5.709 | 6.423 | 6.783 | 6.305 | 5.935 | 5.386 | 4.174 | 4.32 | 2.709 | 2.281 | 1.699 | 1.656 | 1.545 | 1.338 | 1.338 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 4.941 | 5.542 | 5.035 | 5.52 | 6.042 | 6.279 | 6.407 | 6.137 | 5.709 | 6.423 | 6.783 | 6.305 | 5.935 | 5.386 | 4.174 | 4.32 | 2.709 | 2.281 | 1.699 | 1.656 | 1.545 | 1.338 | 1.338 |
Other Expenses
| 0 | -0.017 | -0.001 | -0.021 | 0.004 | -0.006 | 0.027 | 0.02 | 0.013 | -0.031 | -0.041 | 0.007 | 0.003 | 0.063 | -0.052 | 0 | -0.1 | -0.039 | -0.005 | 0 | 0 | 0 | 0 |
Operating Expenses
| 21.888 | 19.798 | 17.859 | 18.543 | 19.628 | 20.122 | 21.48 | 21.162 | 19.375 | 17.885 | 18.619 | 18.472 | 15.097 | 13.05 | 11.674 | 10.501 | 8.701 | 8.085 | 7.654 | 7.355 | 6.44 | 6.413 | 6.413 |
Operating Income
| -21.888 | -20.17 | -18.221 | -18.902 | -19.628 | -20.122 | -21.48 | -21.162 | -19.375 | -17.885 | -18.619 | -18.472 | -15.097 | -13.05 | -11.674 | -10.501 | -8.701 | -8.085 | -7.654 | -7.355 | -6.44 | -6.421 | -6.421 |
Operating Income Ratio
| 0 | 0 | 0 | -11.682 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 2.736 | 2.784 | 2.951 | 3.145 | 2.988 | -0.006 | 2.352 | 1.817 | 1.137 | 0.573 | 0.188 | 0.007 | 0.003 | 0.063 | -0.052 | 0.048 | -0.1 | -0.039 | -0.005 | 0.308 | 0.272 | 0.365 | 0.365 |
Income Before Tax
| -19.152 | -17.386 | -15.27 | -15.757 | -16.64 | -17.432 | -19.128 | -19.345 | -18.238 | -17.312 | -18.431 | -18.359 | -14.992 | -12.874 | -11.598 | -10.453 | -8.761 | -7.967 | -7.253 | -7.047 | -6.168 | -6.056 | -6.056 |
Income Before Tax Ratio
| 0 | 0 | 0 | -9.739 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0.074 | -16.173 | 0.319 | -0.001 | -0.358 | 0.004 | -2.352 | -0.018 | -0.009 | -0.002 | 0.002 | 0.023 | 0.019 | -0.113 | 0.004 | 0.001 | 0.003 | -0.157 | 0.002 | 0 | 0.007 | 0.001 | 0.001 |
Net Income
| -19.226 | -1.213 | -15.27 | -15.756 | -16.64 | -17.436 | -16.776 | -19.327 | -18.229 | -17.31 | -18.433 | -18.359 | -15.011 | -12.874 | -11.602 | -10.454 | -8.764 | -7.967 | -7.255 | -7.047 | -6.175 | -6.057 | -6.057 |
Net Income Ratio
| 0 | 0 | 0 | -9.738 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.37 | -0.024 | -0.3 | -0.31 | -0.34 | -0.38 | -0.37 | -0.42 | -0.4 | -0.38 | -0.41 | -0.41 | -0.33 | -0.29 | -0.26 | -1.74 | -1.46 | -0.19 | -0.23 | -0.23 | -0.2 | -2 | -2 |
EPS Diluted
| -0.37 | -0.024 | -0.3 | -0.31 | -0.34 | -0.38 | -0.37 | -0.42 | -0.4 | -0.38 | -0.41 | -0.41 | -0.33 | -0.29 | -0.26 | -1.74 | -1.46 | -0.19 | -0.23 | -0.23 | -0.2 | -2 | -2 |
EBITDA
| -21.888 | -19.798 | -17.859 | -18.543 | -19.628 | -19.753 | -21.309 | -21.087 | -19.301 | -17.803 | -18.535 | -18.395 | -15.017 | -12.979 | -11.595 | -10.44 | -8.701 | -7.997 | -7.56 | -7.26 | -6.333 | -6.328 | -6.328 |
EBITDA Ratio
| 0 | 0 | 0 | -11.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |